If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
69.00    -1.50 (-2.13%)
Bid:
68.00
Ask:
70.00
Spread: 2.00 (2.941%)
Market Cap: £323.30m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Non-Executive Sam Williams Steps Down After General Meeting

Mon, 04th Nov 2019 18:15

(Alliance News) - Avacta Group PLC on Monday said Sam Williams is stepping down from his role as a non-executive director with immediate effect.

Williams joined the biotechnology company at the end of January, keeping his role of chief executive of life sciences at investment firm IP Group PLC.

"The chairman and board would like to thank Sam for his contribution and look forward to continuing to work with Sam in his role at IP Group as a strongly supportive investor in Avacta," the company said in its statement Monday.

Avacta shares closed 1.9% lower on Monday in London at 15.70 pence each.

By Evelina Grecenko; evelinagrecenko@alliancenews.com

Copyright 2019 Alliance News Limited. All Rights Reserved.

Related News

Avacta Therapeutics appoints Patrick Vink as deputy chair
27 mins ago

Avacta Therapeutics appoints Patrick Vink as deputy chair

(Sharecast News) - Avacta Therapeutics said on Wednesday it had appointed healthcare executive Patrick Vink to its board as non-executive deputy chair...

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta Group News

Avacta Therapeutics appoints Patrick Vink as deputy chair
27 mins ago

Avacta Therapeutics appoints Patrick Vink as deputy chair

(Sharecast News) - Avacta Therapeutics said on Wednesday it had appointed healthcare executive Patrick Vink to its board as non-executive deputy chair...

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities
25 Jun 2026

EARNINGS AND TRADING: Clontarf loss narrows, eyes new opportunities

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

Avacta agrees design of pivotal US cancer therapy trial
25 Jun 2026

Avacta agrees design of pivotal US cancer therapy trial

(Sharecast News) - Avacta said on Thursday it had agreed the design of a pivotal US trial for its lead cancer therapy with the US Food and Drug Admini...

Avacta hails "strong progress" in first half of 2026
22 Jun 2026

Avacta hails "strong progress" in first half of 2026

(Alliance News) - Avacta Group PLC on Monday said it continued its "strong progress" in the first half of 2026.

IN BRIEF: Avacta Group raises GBP9 million for bond repayments
5 Jun 2026

IN BRIEF: Avacta Group raises GBP9 million for bond repayments

Avacta Group PLC - London-based clinical-stage biopharmaceutical company - Raises gross proceeds of approximately GBP9 million from institutional inve...

Avacta to reduce convertible bond debt after £9m placing
5 Jun 2026

Avacta to reduce convertible bond debt after £9m placing

(Sharecast News) - Avacta announced on Friday that it had raised about £9m through an oversubscribed placing with institutional investors and exi...

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value
29 May 2026

EARNINGS AND TRADING: Blencowe updates Orom-Cross net present value

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...